Israeli Cannabis-Based Nanotech Droplets Start US Sales
Nutraceutical pain reliever makes use of marijuana’s CBD compound, doesn’t make you high.
Sales based on Israeli startup Lyotropic Delivery Systems (LDS) Biotech‘s nanotechnology have started in the US. The commercial launch of its cannabis-derived compound, which aims to relieve inflammation and pain, was announced earlier this month by LDS and US based company Ananda Scientific at a marijuana business conference held in Las Vegas.
LDS’s new cannabis-based technology increases the amount of cannabidiol compound (CBD) absorbed into the bloodstream and is more effective than other available solutions, without a narcotic effect, the company said.
LDS and Ananda Scientific, a privately held Delaware corporation that produces and markets cannabis based products, entered into a licensing agreement in 2015. As part of the accord Ananda gained rights to LDS’s cannabinoid drug delivery nanotechnology for the development of cannabidiol (CBD)-based oral products. Ananda Scientific said it expects the sales of the...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
Follow us on Instagram
Connect with us on Linkedin